Information for Tirzepatide
Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system and act as a potent weight loss agent. Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well.
Research Certificates of Analysis
10.15mg
Laboratory ID V250131-1
02/27/2025
22.06mg
Laboratory ID V250131-1
02/27/2025
33.66mg
Laboratory ID V250131-1
02/27/2025
33.78mg
Task #52583
Batch #1002
11/11/2024
30.02mg
Task #48957
Batch #09122024
09/12/2024
Older Research Certificates of Analysis
GMP Certificates of Analysis
27.05mg
Laboratory ID V250606-26 007
06/20/2025
15.02mg
Laboratory ID V250606-26 006
06/20/2025
9.54mg
Laboratory ID V250606-26 005
06/20/2025
10mg
Laboratory ID V250321-20 009
Lot # 11325
04/02/2025
30mg
Laboratory ID V250321-20 010
Lot # 20425
04/02/2025
Tirzepatide Peptide Structure
2D structure image of CID 156588324 (Tirzepatide):
PubChem Identifier: CID 156588324
URL: https://pubchem.ncbi.nlm.nih.gov/compound/156588324
Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS
Note: Aib is a non-coded (non-proteinogenic) amino acid – H2H-C(CH3)2-COOH
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.527 g/mol
CAS Number: 2023788-19-2
Synonyms: P1206, LY3298176
Product Usage
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.
